FDA NDC Directory · JSON-LD · Markdown

Inbrija

NDC 10144-342 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namelevodopa
Labeler / ManufacturerMerz Pharmaceuticals, LLC
Marketing categoryNew Drug Application (innovator) · App NDA209184
Dosage form / routeCAPSULE · RESPIRATORY (INHALATION)
Active ingredientsLEVODOPA (42 mg/1)
Marketing started20181222
Package count6

External sources

Source: openFDA. Public-domain (CC0).